SUBSCRIBE
SUBSCRIBE

Opus Genetics

NEWS
Business
Spark Founders Launch Opus Genetics to Tackle Rare Forms of Blindness
The startup’s initial focus will be on rare blindness conditions affecting pediatric patients.
September 22, 2021
 · 
2 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference
December 11, 2025
 · 
1 min read
Press Releases
Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease
December 10, 2025
 · 
5 min read
Press Releases
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 2, 2025
December 3, 2025
 · 
2 min read
Press Releases
Opus Genetics to Participate in Upcoming Investment Conferences
November 21, 2025
 · 
1 min read
Press Releases
Opus Genetics Announces Dosing of First Participant in OPGx-BEST1 Phase 1/2 Gene Therapy Clinical Trial for Best Disease
November 14, 2025
 · 
6 min read
Press Releases
Opus Genetics Announces Financial Results for Third Quarter 2025 and Provides Corporate Update
November 13, 2025
 · 
12 min read
Press Releases
Opus Genetics Announces Successful FDA Meeting Supporting Advancement of OPGx-LCA5 Toward Pivotal Trial for LCA5-Related Inherited Retinal Disease
November 6, 2025
 · 
8 min read
Press Releases
Opus Genetics Announces $23 Million Registered Direct Offering
November 6, 2025
 · 
5 min read
Press Releases
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 4, 2025
November 4, 2025
 · 
2 min read
Press Releases
Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness
November 4, 2025
 · 
4 min read
Load More